Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Apr 24, 2013 · 10-Q · 24 days after period end · 0001193125-13-170549
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $1.96M | $2.97M | $3.24M |
| Net Income | -$408.00K | $30.00K | -$207.00K |
| EPS Diluted | -$0.01 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed Apr 24, 2013 · 24 d after period end
